Analysis of the Epidemiological Situation on the Pneumonia with Signs of Coronavirus Infection among the Population of the Republic of Kazakhstan
DOI:
https://doi.org/10.3889/oamjms.2022.9327Keywords:
Republic of Kazakhstan, Coronavirus infection, Pneumonia with signs of coronavirus infection, Number of sick, Recovered and fatal casesAbstract
New coronavirus infection caused by SARS-CoV-2 (COVID-19), as well as pneumonia with signs of coronavirus infection, continues to spread around the world, but the epidemiological situation is not the same in different countries.
The aim of the study: to analyze the epidemiological situation of coronavirus infection and pneumonia with signs of coronavirus infection in the Republic of Kazakhstan.
Material and methods of the research: retrospective epidemiological analysis of the incidence of coronavirus infection and pneumonia with signs of coronavirus infection in the republic according to official statistical reporting, as well as a statistical analysis of discharge records of patients diagnosed with coronavirus infection (no virus identified) in a small town of Karaganda region was carried out.
Results: An increase in cases, sick persons, recovered persons and lethal cases in population with positive PCR for COVID-19, as well as pneumonia with signs of coronavirus infection in the Republic of Kazakhstan was registered for the period from 08/01/2020 to 12/31/2021. The number of cases of coronavirus increased in 10.93 time, those who recovered – in 15.78 times, deaths – in 16.4 time, respectively. The increase in the number of cases of pneumonia with signs of coronavirus infection also increased in 16.24 time, the number of those who recovered at the beginning of the observation was not established, by the end the number of recovered was 76,989 people, the number of deaths increased in 173.83 time.
Conclusion: An analysis of the discharge records of patients with pneumonia with signs of coronavirus infection revealed that 54.2% of the patients were females and 45.8% were males. The disease was registered in 21.8% of patients older than 60 years in the presence of concomitant diseases. Concomitant diseases were represented in 42% by arterial hypertension, in 26% by ischemic heart disease, in 14% by pyelonephritis. The same percentage of cases (12%) were chronic obstructive pulmonary disease and iron deficiency anemia, 11%
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Meskina R. Preliminary clinical and epidemiological analysis of the first 1000 cases of COVID-19 in children in the Moscow region. J Microbiol Epidemiol Immunol. 2020;97(3):202-13. https://doi.org/10.36233/0372-9311-2020-97-3-2 DOI: https://doi.org/10.36233/0372-9311-2020-97-3-2
Maukayeva SB, Tokayeva AZ, Isabekova ZB, Smail M, Nuralinova GI, Trenina VA, et al. COVID-19 in Kazakhstan and the east Kazakhstan region. Sci Health. 2020;3(22):12-16. https://doi.org/10.34689/SH.2020.22.3.002
Berseneva YA, Agamov ZK, Mikhailov DY. Problems of the average statistical spread of diseases (ICD-10) when coding morbidity and mortality. Prev Med. 2021;24(4):132-7. https://doi.org/10.17116/profmed202124041132 DOI: https://doi.org/10.17116/profmed202124041132
Drapkina OM, Samorodskaya IV, Sivtseva MG, Kakorina YP, Briko NI, Cherkasov SN, et al. Methodological aspects of assessment incidence, prevalence, mortality and mortality associated with COVID-19. Cardiovasc Ther Prev. 2020;19(3):2585. https://doi.org/10.15829/1728-8800-2020-2585 DOI: https://doi.org/10.15829/1728-8800-2020-2585
Kobyakova OS, Polikarpov AV, Golubev NA, Ryabkov IV, Lisnenko AA. Transformation of medical statistics during the pandemic of a new coronavirus infection (COVID-19). Probl Soc Hyg Health Care Med Hist. 2021;29(6):1439-45. https://doi.org/10.32687/0869-866X-2021-29-6-1439-1445 DOI: https://doi.org/10.32687/0869-866X-2021-29-6-1439-1445
Mitkovskaya NP, Karpov IA, Arutyunov GP, Grigorenko EA, Ruzanov DYU, Statkevich TV, et al. Coronavirus infection COVID-19 (review of international scientific data). In: Urgent Cardiology and Cardiovascular Risks. 2020;4(1):784-815.
Bolekhan VN, Uliukin IM, Peleshok SA. Features of the development of the COVID-19 pandemic. In: Medicо-Biological and Socio-Psychological Problems of Safety in Emerge ncy Situations. 2020. p. 16-26. DOI: https://doi.org/10.25016/2541-7487-2020-0-4-16-26
Shchelkanov MY, Kolobukhina LV, Burgasova OA, Kruzhkova IS, Maleev VV. COVID-19: Etiology, clinic, treatment. Infect Immunity. 2020;10(3):421-45. https://doi.org/10.15789/2220-7619-CEC-1473 DOI: https://doi.org/10.15789/2220-7619-CEC-1473
Panasyuk YV, Churilova NS, Vlasenko NV. Characteristics of the Epidemiological Situation on Covid-19 in the Nizhny Novgorod Region from February 26, 2020 to July 22. All-Russian Scientific and Practical Conference with International Participation Molecular Diagnostics and Safety; 2020. p. 165-7. DOI: https://doi.org/10.36233/978-5-9900432-9-9-165
Malinnikova YY. New coronavirus infection. Today’s look at the pandemic of the XXI century. Infect Dis. 2020;9(2):18-32. https://doi.org/10.33029/2305-3496-2020-9-2-18-32 DOI: https://doi.org/10.33029/2305-3496-2020-9-2-18-32
Starshinova AA, Kushnareva YA, Malkova AM, Dovgalyuk IF, Kudlay DA. New coronavirus infection: Features of the clinical course, the possibilities of diagnosis, treatment and prevention of infection in adults and children. Issues Mod Pediatr. 2020;19(2):123-131. https://doi.org/10.15690/vsp.v19i2.2105 DOI: https://doi.org/10.15690/vsp.v19i2.2105
Kutyrev VV, Popova AYu, Smolensky VYu, Ezhlova EB, Demina YuV, Safronov VA, et al. (COVID-19) Communication 1: Modes of implementation of preventive and anti-epidemic measures. Problems of Particularly Dangerous Infections; 2020. p. 6-13. https://doi.org/10.21055/0370-1069-2020-1-6-13 DOI: https://doi.org/10.21055/0370-1069-2020-1-6-13
Akimkin VG, Kuzin SN, Semenenko TA, Ploskireva AA, Dubodelov DV, Tivanova EV, et al. Gender and Age Characteristics of Patients with COVID-19 at Different Stages of the Epidemic in Moscow. Problems of Especially Dangerous Infections; 2020. p. 27-35. https://doi.org/10.21055/0370-1069-2020-3-27-35 DOI: https://doi.org/10.21055/0370-1069-2020-3-27-35
COVID-19: First Experience. In: Zotov PB, editor. Collective Monograph; 2020. Tyumen: Vector-Buk; 2021. p. 463.
Chayakova A, Dauletyarova M, Aldyngurov D, Mussina A, Suleimenova R, Utegenova A, et al. Trends of emergency calls during the coronavirus disease-19 pandemic in Nur-Sultan. Open Access Maced J Med Sci. 2021;9:665-9. https://doi.org/10.3889/oamjms.2021.6629 DOI: https://doi.org/10.3889/oamjms.2021.6629
Vidal-Alaball J, Acosta-Roja R, Hernández NP, Luque US, Morrison D, Pérez SN, et al. Telemedicine in the face of the COVID-19 pandemic. Aten Prim. 2020;52(6):418-22. https://doi.org/10.1016/j.aprim.2020.04.003 DOI: https://doi.org/10.1016/j.aprim.2020.04.003
Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A. 2020;117(17):9241‐3. https://doi.org/10.1073/pnas.2004999117 PMid:32269081 DOI: https://doi.org/10.1073/pnas.2004999117
Guidance COVID-19: Investigation and Initial Clinical Management of Possible Cases. Available from: https://www.gov.uk/government/publications [Last accessed on 2020 Apr 27].
Coronavirus Disease 2019 (COVID-19): Epidemiology, Virology, Clinical Features, Diagnosis, and Prevention; 2020. Available from: https://www.uptodate.com [Last accessed on 2020 Apr 30].
Grubaugh ND, Hanage WP, Rasmussen AL. Making sense of mutation: What D614G means for the COVID-19 pandemic remains unclear. Cell 2020;182:794-5. DOI: https://doi.org/10.1016/j.cell.2020.06.040
Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020;81:104260. https://doi.org/10.1016/j.meegid.2020.104260 DOI: https://doi.org/10.1016/j.meegid.2020.104260
Rambaut A, Loman N, Pybus O, Barclay W, Barrett J, Carabelli A, et al. Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel Set of Spike Mutations; 2020. Available from: https://www.cogconsortium.uk [Last accessed on 2020 Dec 18].
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Fatima Meirkhankyzy Shaizadina, Kymbat Eraliyevna Amreyeva, Zulfiya Meirkhanovna Zhankalova, Zhaniya Abaevna Dauletkaliyeva, Gaziza Temiralikyzy Abuova, Nessipkul Oryntaevna Alysheva, Mauza Maralovna Beisekova, Aisulu Makashovna Kamarova, Nurzhamal Utebayevna Shintayeva, Asem Zhakenovna Zhienbekova (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0